Comprehensive Medical Weight Loss Denver
For years, the headline around obesity in America has been relentless growth. More people, higher BMI, more disease. The trajectory looked inevitable — up and to the right, year after year. That may finally be changing. New data from EPIC…
CVS just flipped the script on GLP-1 coverage — and if you’ve been stuck paying out of pocket because your plan dropped Zepbound, this matters. What’s changing: CVS Caremark, one of the nation’s largest pharmacy benefit managers, will restore coverage…
New research confirms what many of us in obesity medicine have suspected for years — GLP-1 drugs do more than help people lose weight. They protect the heart. — A massive review of more than 90,000 participants across 11 major…
Eli Lilly’s triple-action GLP-1 drug delivered striking results in the Phase III TRIUMPH-4 trial — and the knee pain data might be the most remarkable part. — If you’ve been watching the GLP-1 space, retatrutide isn’t news. But the Phase…
If you’re on a GLP-1 medication and have noticed more hair in the shower drain, you’re not imagining it. A new meta-analysis published in Science Progress (Gupta et al., PMID 41998799) confirms what many patients and clinicians have already suspected:…
📌 CNC’s Complete Medicare Guide (Updated July 1, 2026) For the full, up-to-date reference on the Medicare GLP-1 Bridge program — including who qualifies, what it costs, the CNC prior authorization process, and how to start — see our Medicare…
Most people on a GLP-1 medication hit a wall around 12-16 weeks. The scale stops moving. The dose feels like it is not doing anything anymore. Patients often feel like they have failed — but they have not. They have…
The newest GLP-1 medication just landed in pharmacies: oral semaglutide. Novo Nordisk launched it in January 2026 after FDA approval based on the OASIS 4 trial, which showed 13.6% average weight loss over 64 weeks. That’s solid. But the real…
Wegovy HD vs Zepbound: Comparing GLP-1 weight loss medications Your patients are asking: Should I take Wegovy or Zepbound? The answer used to be “either one works great.” But 2026 just got more complicated—and more interesting. The Old Winner For…
You’ve heard the success stories. Patients lose 15–20% of their body weight on GLP-1 medications. Life-changing results. But here’s the uncomfortable truth that nobody talks about at lunch: most of them don’t stay on these drugs. The Real-World Data A…
